Buscar
IDEXX Laboratories Inc
IDXXAñadir a la lista de seguimiento
520.050USD
-0.160-0.03%
Horarios del mercado 09/09, 09:58（ET）
41.02BCap. mercado
38.00P/E TTM
Más Datos de IDEXX Laboratories Inc Compañía
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
Perfil de IDEXX Laboratories Inc
Símbolo de cotizaciónIDXX
Nombre de la empresaIDEXX Laboratories Inc
Fecha de salida a bolsaJun 21, 1991
Director ejecutivoEmerson (Andrew)
Número de empleados11000
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 21
DirecciónOne Idexx Drive
CiudadWESTBROOK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal04092-2041
Teléfono12075560300
Sitio Webhttps://www.idexx.com/
Símbolo de cotizaciónIDXX
Fecha de salida a bolsaJun 21, 1991
Director ejecutivoEmerson (Andrew)
Ejecutivos de IDEXX Laboratories Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.34K
+4.13%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.35K
+7.66%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager - Veterinary Software, Diagnostic Imaging and Telemedicine, Corporate Accounts and Customer Experience
Executive Vice President and General Manager - Veterinary Software, Diagnostic Imaging and Telemedicine, Corporate Accounts and Customer Experience
3.00K
+36.06%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.34K
+4.13%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de IDEXX Laboratories Inc?
Los cinco principales accionistas de IDEXX Laboratories Inc son: Mr. Michael G. (Mike) Erickson, Ph.D.
¿Cuántas instituciones poseen acciones de IDEXX Laboratories Inc (IDXX)?
A fecha de 2026Q1, 2458 instituciones poseen acciones de IDEXX Laboratories Inc, con un valor de mercado combinado de aproximadamente 76.16M, lo que representa el 96.54% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2089033.00.
¿Cuál es la mayor fuente de ganancias de IDEXX Laboratories Inc?
El 2026Q1, el segmento empresarial CAG Diagnostics recurring revenue generó la ganancia más alta para IDEXX Laboratories Inc, ascendiendo a 974.71M y representando el 80.12% de la ganancia total.